Category: Uses and Disclosures

Data Aggregation Services

Also known as: Data Aggregation, Data Aggregation (HIPAA)

Simply put

Data aggregation services generally involve combining protected health information from more than one covered entity so it can be analyzed together, for example to compare or summarize data across organizations. Under HIPAA, when a vendor performs this kind of service for a covered entity in a way that requires it to handle protected health information, that vendor typically becomes a business associate. This means the service must be governed by a business associate agreement and the associated HIPAA obligations.

Formal definition

Under the HIPAA Privacy Rule, data aggregation is a defined service in which a business associate combines the protected health information (PHI) it receives or creates on behalf of one covered entity with the PHI it receives or creates on behalf of other covered entities, to permit data analyses relating to the health care operations of the respective covered entities. Performance of this service gives rise to a business associate relationship where it involves the disclosure of PHI, and it must therefore be addressed through a compliant business associate agreement (BAA) that specifies permitted uses and disclosures. The term has a narrow, defined regulatory meaning under HIPAA that differs from the broader general-industry usage of 'data aggregation' (i.e., consolidating data from multiple sources for analytics); practitioners should not treat the two as interchangeable. This entry addresses only the HIPAA Privacy Rule characterization of the service and the resulting business associate obligations; it does not address applicable Security Rule safeguards for electronic PHI, Breach Notification Rule duties, state-law requirements, or HITECH Act provisions that may impose additional obligations. Readers should verify the precise definition and associated permitted-use provisions against the current regulatory text at 45 CFR Part 164.

Why it matters

Data aggregation carries a specific, narrow meaning under the HIPAA Privacy Rule that differs from how the term is used in the broader technology and analytics industries. In general-industry usage, data aggregation simply refers to consolidating data from multiple sources for analytics or reporting. Under HIPAA, however, it refers to a defined service in which a business associate combines the protected health information it handles on behalf of one covered entity with PHI it handles on behalf of other covered entities, to permit analyses relating to those covered entities' health care operations. Treating the two meanings as interchangeable can lead compliance teams to misclassify a vendor relationship or to overlook the business associate obligations that attach.

The practical significance is that performing this service generally gives rise to a business associate relationship where it involves the disclosure of PHI. That means the arrangement typically must be governed by a compliant business associate agreement (BAA) that specifies the permitted uses and disclosures. Because data aggregation permits a business associate to combine PHI across multiple covered entities, the BAA terms defining what the vendor may and may not do with that combined information are especially important; without an appropriate agreement in place, the underlying disclosures may fall outside what the Privacy Rule permits.

Organizations should also recognize what this characterization does not cover. The Privacy Rule's treatment of data aggregation addresses the permitted-use and business associate framing, but it does not by itself address Security Rule safeguards for electronic PHI, Breach Notification Rule duties, state-law requirements, or HITECH Act provisions, any of which may impose additional obligations. Compliance teams should verify the precise definition and permitted-use provisions against the current regulatory text at 45 CFR Part 164.

Who it's relevant to

Privacy Officers

Privacy officers are responsible for determining whether a vendor's activity meets the HIPAA-specific definition of data aggregation and whether it gives rise to a business associate relationship. They should ensure the distinction between the regulatory meaning and general-industry usage of the term is understood so that vendor relationships are classified correctly and permitted uses and disclosures are properly documented.

Compliance and Legal Teams

Because performing data aggregation typically requires a compliant business associate agreement, compliance and legal teams need to ensure that any BAA covering the service specifies the permitted uses and disclosures, including whether and how PHI may be combined across covered entities. They should also verify the precise definition and permitted-use provisions against the current text at 45 CFR Part 164.

Business Associates and Analytics Vendors

Vendors that combine PHI from multiple covered entities to support health care operations analyses may fall within the HIPAA definition of a data aggregation service and become business associates where disclosure of PHI is involved. Such vendors should confirm that a compliant BAA is in place and that their handling of combined PHI stays within its permitted-use terms.

Covered Entities Engaging Vendors

Covered entities that engage a vendor to aggregate their PHI with that of other organizations should confirm the arrangement is governed by an appropriate business associate agreement and understand that the Privacy Rule characterization does not by itself resolve Security Rule, breach notification, state-law, or HITECH obligations that may also apply.

Inside Data Aggregation Services

Data Aggregation (Privacy Rule definition)

Under the HIPAA Privacy Rule, data aggregation refers to the combining of protected health information (PHI) by a business associate on behalf of multiple covered entities to permit data analyses that relate to the health care operations of the respective covered entities. This is a defined regulatory term with a narrower meaning than the general industry use of 'data aggregation.'

Business Associate Relationship

Data aggregation services are typically performed by a business associate, not a covered entity acting directly. The permission to combine PHI from multiple covered entities flows through business associate agreements (BAAs) and applies only to the extent the activity qualifies as a permitted health care operation.

Business Associate Agreement (BAA) Provisions

A BAA may specifically authorize the business associate to use PHI to provide data aggregation services relating to the health care operations of the covered entity. Absent such authorization, the business associate is generally limited to the uses and disclosures permitted by the agreement and the Privacy Rule.

Health Care Operations Nexus

The permissibility of data aggregation is tied to the health care operations of the covered entities whose PHI is combined. The analysis must relate to those operations rather than to purposes outside the scope of what the Privacy Rule and the BAA permit.

Scope Boundary (PHI in all forms)

Because data aggregation is a Privacy Rule concept, it concerns PHI in all forms (electronic, paper, and oral), not solely electronic PHI. Separately, the Security Rule's safeguard obligations apply to any ePHI involved in these services.

Common questions

Answers to the questions practitioners most commonly ask about Data Aggregation Services.

Can a business associate combine PHI from multiple covered entities for any purpose it chooses?

No. The data aggregation exception under the Privacy Rule permits a business associate to combine PHI received in its capacity as a business associate of different covered entities, but only to perform analyses that relate to the health care operations of the respective covered entities. It does not authorize the business associate to use the aggregated data for its own independent purposes. Any permitted data aggregation activity should be expressly addressed in the applicable business associate agreements, and covered entities should verify the specific scope against the current regulatory text.

Is 'data aggregation' just another term for de-identifying or anonymizing data?

No. In its HIPAA regulatory sense, data aggregation refers to a business associate combining PHI from multiple covered entities to permit data analyses relating to those covered entities' health care operations. The data typically remains PHI throughout this process. De-identification is a separate concept with its own standards under the Privacy Rule, and aggregating identifiable data does not by itself render that data de-identified. Readers should not treat the two terms as interchangeable.

How should data aggregation services be documented in a business associate agreement?

Because data aggregation is a specific permitted activity rather than a default one, the business associate agreement should expressly state whether the business associate is authorized to perform data aggregation services and describe the scope of that authorization. Where a business associate serves multiple covered entities, each applicable agreement generally needs to reflect the permitted activity. Covered entities should confirm the required contractual provisions against the current regulatory requirements for business associate agreements.

Do the Security Rule safeguards still apply to aggregated ePHI?

Yes. When aggregated data exists in electronic form, it is ePHI and remains subject to the Security Rule's administrative, physical, and technical safeguards, including both required and addressable implementation specifications. Combining data from multiple sources may increase the sensitivity and volume of ePHI in one location, which is a factor a business associate would typically consider in its risk analysis. Addressable specifications are not optional and must be addressed through implementation or documented justification and reasonable alternatives.

What should a covered entity confirm before allowing a business associate to aggregate its PHI with data from others?

A covered entity should generally confirm that the intended analyses relate to health care operations as defined by the Privacy Rule, that the business associate agreement expressly permits data aggregation, and that appropriate safeguards are in place to protect the combined data. The covered entity should also consider whether state law, the HITECH Act, or contractual commitments impose additional requirements beyond HIPAA, and verify the permitted scope against current regulatory guidance.

Does using a HITRUST-certified vendor for data aggregation establish HIPAA compliance for this activity?

No. HITRUST is a private organization and the HITRUST CSF is a certifiable control framework; certification is not a legal requirement and does not by itself establish HIPAA compliance. A HITRUST certification may support a vendor's security posture, but the permissibility of data aggregation still depends on the terms of the business associate agreement and the requirements of the Privacy and Security Rules. Compliance obligations under HIPAA are enforced by HHS OCR and should be assessed independently of any certification.

Common misconceptions

Data aggregation lets a business associate freely combine and reuse PHI from all its clients for any analytic purpose.

The Privacy Rule permits data aggregation only where it relates to the health care operations of the respective covered entities and only where the applicable business associate agreement authorizes it. It is not a general license to pool and repurpose PHI for unrelated purposes.

'Data aggregation' in HIPAA means the same thing as the common IT industry use of the term.

HIPAA gives 'data aggregation' a specific regulatory definition tied to combining PHI on behalf of multiple covered entities for their health care operations. This differs from generic usage referring to any consolidation of data, so practitioners should apply the regulatory meaning in a compliance context.

If aggregated data is de-identified, HIPAA no longer plays any role in the arrangement.

Data that meets the Privacy Rule's de-identification standard is generally no longer PHI, but the aggregation activity that combines identifiable PHI to produce those analyses still occurs under the Privacy Rule and the BAA. Readers should confirm de-identification requirements against the current regulation before treating outputs as outside HIPAA's scope.

Best practices

Confirm that the business associate agreement expressly authorizes data aggregation services before combining PHI from multiple covered entities, since this permission is not implied.

Document how each aggregation activity relates to the health care operations of the covered entities involved, and avoid extending the activity to purposes not permitted by the Privacy Rule or the BAA.

Apply appropriate Security Rule administrative, physical, and technical safeguards to any ePHI involved in aggregation, treating addressable implementation specifications as requirements to be evaluated and documented rather than optional.

Where outputs are intended to be de-identified, verify the de-identification approach against the current Privacy Rule standard and retain documentation of the method used.

Check whether state law or the HITECH Act imposes additional restrictions beyond HIPAA on combining or using health data, and reconcile any stricter requirements.

Do not treat HITRUST CSF certification, if used by the business associate, as a substitute for these HIPAA obligations; certification does not by itself establish HIPAA compliance and should be verified against the current CSF version.